Financials Ziyuanyuan Holdings Group Limited
Equities
8223
KYG9898B1041
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 HKD | -1.88% | -7.65% | -13.74% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 298.5 | 375.3 | 397.3 | 814.8 | 582.9 | 661.7 |
Enterprise Value (EV) 1 | 303.6 | 424.1 | 423.4 | 950.3 | 815.5 | 697.1 |
P/E ratio | 15.3 x | 22.2 x | 30.6 x | 148 x | 36.9 x | 45.4 x |
Yield | - | 2.86% | 2.12% | 1% | 1.52% | - |
Capitalization / Revenue | 6.49 x | 6.99 x | 8.14 x | 7.46 x | 1.91 x | 1.38 x |
EV / Revenue | 6.6 x | 7.9 x | 8.68 x | 8.7 x | 2.67 x | 1.46 x |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - |
Price to Book | 1.05 x | 1.25 x | 1.31 x | 2.72 x | 1.9 x | 2.12 x |
Nbr of stocks (in thousands) | 400,000 | 400,000 | 400,000 | 400,000 | 400,000 | 400,000 |
Reference price 2 | 0.7464 | 0.9384 | 0.9932 | 2.037 | 1.457 | 1.654 |
Announcement Date | 28/03/19 | 31/03/20 | 30/03/21 | 22/04/22 | 31/03/23 | 26/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 45.98 | 53.66 | 48.78 | 109.3 | 305.4 | 478.6 |
EBITDA | - | - | - | - | - | - |
EBIT | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | 22.96 | 26.45 | 15.16 | 6.166 | 22.94 | 18 |
Net income 1 | 16.94 | 16.87 | 12.98 | 5.488 | 15.81 | 14.56 |
Net margin | 36.85% | 31.44% | 26.61% | 5.02% | 5.18% | 3.04% |
EPS 2 | 0.0487 | 0.0422 | 0.0325 | 0.0137 | 0.0395 | 0.0364 |
Free Cash Flow | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | 0.0268 | 0.0211 | 0.0204 | 0.0221 | - |
Announcement Date | 28/03/19 | 31/03/20 | 30/03/21 | 22/04/22 | 31/03/23 | 26/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 5.06 | 48.8 | 26.1 | 136 | 233 | 35.4 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | 6.86% | 5.78% | 4.27% | 2.12% | 5.02% | 4.43% |
ROA (Net income/ Total Assets) | 4.49% | 4.07% | 2.98% | 1.33% | 2.72% | 2.28% |
Assets 1 | 377.7 | 415 | 436.3 | 414.1 | 581.8 | 639.4 |
Book Value Per Share 2 | 0.7100 | 0.7500 | 0.7600 | 0.7500 | 0.7700 | 0.7800 |
Cash Flow per Share 2 | 0.0600 | 0.0600 | 0.2100 | 0.0800 | 0.0300 | 0.2700 |
Capex 1 | 0.05 | 7.22 | 8.67 | 1.54 | 1.62 | 1.53 |
Capex / Sales | 0.12% | 13.46% | 17.77% | 1.41% | 0.53% | 0.32% |
Announcement Date | 28/03/19 | 31/03/20 | 30/03/21 | 22/04/22 | 31/03/23 | 26/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-13.74% | 86.4M | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+24.51% | 32.3B | |
+3.43% | 26.53B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- 8223 Stock
- Financials Ziyuanyuan Holdings Group Limited